Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome

• Glavni autori: Hande Erman (Autor), Engin Beydogan (Autor), Seher Irem Cetin (Autor), Banu Boyuk (Autor)
• Format: Knjiga
• Izdano: Hindawi Limited, 2020-01-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background. Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, which has recently been mentioned as an independent cardiovascular risk factor. Objectives. Endocan is a novel molecule of endothelial dysfunction. We aimed to evaluate the associations of serum en...